North Huajin Chemical Industries Co Ltd

North Huajin Chemical Industries Co Ltd has a debt-to-equity ratio of 0.82, indicating a moderate level of leverage, and a current ratio of 3.83, suggesting strong short-term liquidity. However, the company reported negative operating cash flow of -3.05 billion CNY and a net loss of -241.77 million CNY, signaling financial stress in the most recent period. The company's return on equity is -1.78%, and return on assets is -0.86%, both significantly below the industry median for profitability and capital efficiency.

The company's operating income was -211.24 million CNY, and gross profit was only 320.40 million CNY, indicating weak pricing power and cost control. These figures are far below the industry median for gross margin and operating margin, suggesting operational inefficiencies or competitive pressures. The company's capital expenditures were -92.08 million CNY, a modest outlay relative to its asset base, but insufficient to offset declining profitability.

North Huajin's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's total revenue of 11.71 billion CNY is derived from commodity chemical production, which is highly sensitive to global demand and raw material prices. The lack of segment or geographic diversification increases exposure to sector-specific risks, such as commodity price volatility and regulatory changes in China.

The company's growth trajectory is negative, with no disclosed revenue growth in the most recent period. Analysts have assigned a mean price target of 7.60 CNY, with a single "buy" recommendation and no "strong buy" ratings, reflecting cautious sentiment. The company's operating cash flow and net income are both negative, and its liquidity risk is rated as medium, indicating potential challenges in meeting short-term obligations.

The company's risk profile includes a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's financial vulnerability. No dilution sources were identified in the most recent filings, and the company has not issued new shares in the past year. The absence of dilution pressure is a positive, but the company's financial performance remains a concern.

Recent filings and transcripts show no material changes in the company's operations or strategy. The company continues to operate in a highly competitive and cyclical industry, with limited visibility on cost-reduction initiatives or new product development. The lack of innovation or diversification may hinder long-term growth prospects.

North Huajin Chemical Industries Co Ltd (000059.SZ) has undergone a significant update to its fundamental classification, now formally categorized within the Chemicals activity and the Basic Materials economic sector. This structural definition provides a clearer framework for understanding the company's operational focus and industry positioning, marking a medium-severity change in its tracked profile. Alongside this sectoral clarification, the company’s risk assessment profile has been initialized with specific metrics. The dilution risk is now classified as low, indicating a stable capital structure with minimal threat of share value erosion from new issuances. This assessment offers investors greater confidence regarding the preservation of existing equity value. Conversely, the liquidity risk has been established at a medium level. This designation suggests that while the company maintains operational fluidity, there are moderate considerations regarding the ease of converting assets to cash or managing short-term obligations. This balanced risk view is essential for evaluating the firm's financial resilience within the broader basic materials landscape. These updates collectively refine the analytical baseline for North Huajin Chemical Industries, shifting from an undefined state to a structured profile with clear sectoral and risk attributes. The combination of low dilution risk and medium liquidity risk, set against the backdrop of the Chemicals sector, provides a more nuanced foundation for future financial and operational analysis.

Analysts project 52% upside to a target price of 7.6 CNY, signaling strong institutional confidence in the stock's valuation.

Free cash flow improved by 55.2% year-over-year, demonstrating significant operational efficiency and liquidity generation capabilities.

Revenue grew 20.7% year-over-year to 41.8 billion CNY, indicating robust top-line expansion despite margin pressures.

Cash conversion ratio of 12.63 ranks best-in-class among 600 peers, highlighting superior cash management relative to competitors.

Gross profit turned positive at 542 million CNY in FY2026, suggesting a potential stabilization in core production economics.

The company faces high credit risk, indicating significant concerns regarding its ability to meet financial obligations.

Net income plummeted to a 2.8 billion CNY loss in FY2025, reflecting severe profitability deterioration and operational distress.

Operating and net margins rank in the bottom quartile of the commodity chemicals cohort, showing weak competitive positioning.

Return on equity remains negative at -1.78%, failing to generate value for shareholders compared to the 3.61% peer median.

Debt-to-equity ratio of 0.82 significantly exceeds the 0.31 cohort median, indicating elevated leverage and financial risk.

Revenue ¥10.19B, +205,3% YoY; Operating income +67,7% YoY.

• ▍Revenue ¥10.19B, +205,3% YoY
• ▍Operating income +67,7% YoY
• ▍Net income +64,7% YoY
• ▍Net margin -4.0%

Revenue ¥10.94B, −6,6% YoY; Operating income −200,4% YoY.

• ▍Revenue ¥10.94B, −6,6% YoY
• ▍Operating income −200,4% YoY
• ▍Net income −167,7% YoY
• ▍Net margin -5.9%

Revenue ¥9.16B; Operating income -¥293.7M.

• ▍Revenue ¥9.16B
• ▍Operating income -¥293.7M
• ▍Net margin -3.7%

Revenue ¥10.10B; Operating income -¥924.7M.

• ▍Revenue ¥10.10B
• ▍Operating income -¥924.7M
• ▍Net margin -9.0%

Revenue ¥3.34B; Operating income -¥1.26B.

• ▍Revenue ¥3.34B
• ▍Operating income -¥1.26B
• ▍Net margin -34.4%

Revenue ¥11.71B; Operating income -¥211.2M.

• ▍Revenue ¥11.71B
• ▍Operating income -¥211.2M
• ▍Net margin -2.1%

Revenue ¥41.76B, +20,7% YoY; Operating income +40,8% YoY.

• ▍Revenue ¥41.76B, +20,7% YoY
• ▍Operating income +40,8% YoY
• ▍Net income +36,9% YoY
• ▍Free cash flow +55,2% YoY
• ▍Net margin -4.2%

Revenue ¥34.60B, −25,0% YoY; Operating income −2 861,1% YoY.

• ▍Revenue ¥34.60B, −25,0% YoY
• ▍Operating income −2 861,1% YoY
• ▍Net income −4 075,5% YoY
• ▍Free cash flow −471,3% YoY
• ▍Net margin -8.1%

Revenue ¥46.14B, −6,0% YoY; Operating income −86,7% YoY.

• ▍Revenue ¥46.14B, −6,0% YoY
• ▍Operating income −86,7% YoY
• ▍Net income −86,7% YoY
• ▍Free cash flow −37,5% YoY
• ▍Net margin 0.2%

Revenue ¥49.06B, +26,9% YoY; Operating income −30,4% YoY.

• ▍Revenue ¥49.06B, +26,9% YoY
• ▍Operating income −30,4% YoY
• ▍Net income −43,9% YoY
• ▍Free cash flow +5,7% YoY
• ▍Net margin 1.1%

Revenue ¥38.65B; Operating income ¥1.14B.

• ▍Revenue ¥38.65B
• ▍Operating income ¥1.14B
• ▍Net margin 2.4%